Should we abandon vancomycin for treatment of methicillin-resistant staphylococcus aureus pneumonia? still questions to answer

Clinical Infectious Diseases

Volumn 55, Issue 1, 2012, Pages 161-163

  Taccone, Fabio Silvio ^a   Vincent, Jean Louis ^a   Denis, Olivier ^a   Jacobs, Frédérique ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

LINEZOLID; VANCOMYCIN;

CONTINUOUS INFUSION; CREATININE CLEARANCE; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG EXCRETION; HUMAN; KIDNEY CLEARANCE; LETTER; LOADING DRUG DOSE; LUNG; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MINIMUM INHIBITORY CONCENTRATION; MONTE CARLO METHOD; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ACETAMIDES; ANTI-BACTERIAL AGENTS; CROSS INFECTION; FEMALE; HUMANS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; OXAZOLIDINONES; PNEUMONIA, STAPHYLOCOCCAL;

EID: 84862232815     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cis332     Document Type: Letter

References (11)

1. Wunderink RG, Niederman MS, Kollef MH, et al. Linezolid in methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a randomized, controlled study. Clin Infect Dis 2012; 54:621-9.
2. Sakoulas G, Moellering RC Jr. Increasing antibiotic resistance among methicillin-resistant Staphylococcus aureus strains. Clin Infect Dis 2008; 46 (Suppl):S360-7.
3. Wunderink RG, Mendelson MH, Smero MS. Early microbiological response to linezolid vs vancomycin in ventilator-associated pneumonia due to methicillin-resistant Staphylococcus aureus. Chest 2008; 134:1200-7.
4. Chung J, Oh JM, Cho EM, et al. Optimal dose of vancomycin for treating methicillinresistant Staphylococcus aureus pneumonia in critically ill patients. Anaesth Intensive Care 2011; 39:1030-7.
5. Ocampos-Martinez E, Penaccini L, Scolletta S, et al. Determinants of early inadequate vancomycin concentrations during continuous infusion in septic patients. Int J Antimicrob Agents 2012; 39:332-7.
6. Rodvold KA, Blum RA, Fischer JH, et al. Vancomycin pharmacokinetics in patients with various degrees of renal function. Antimicrob Agents Chemother 1988; 32:848-52.
7. Udy AA, Varghese JM, Altukroni M, et al. Sub-therapeutic initial β-lactam concentrations in select critically ill patients: association between augmented renal clearance and low trough drug concentrations. Chest 2011. [Epub ahead of print].
8. Kullar R, Davis SL, Levine DP, Rybak MJ. Impact of vancomycin exposure on outcomes in patients with methicillin-resistant Staphylococcus aureus bacteremia: support for consensus guidelines suggested targets. Clin Infect Dis 2011; 52:975-81.
9. Wang JT, Fang CT, Chen YC, Chang SC. Necessity of a loading dose when using vancomycin in critically ill patients. J Antimicrob Chemother 2001; 47:246.
10. Roberts JA, Taccone FS, Udy AA, Vincent JL, Jacobs F, Lipman J. Vancomycin dosing in critically ill patients: robust methods for improved continuous-infusion regimens. Antimicrob Agents Chemother 2011; 55:2704-9.
11. Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin- resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis 2011; 52:e18-55.